Pityriasis Rubra Pilaris: Clinical Trials

6 trials for Pityriasis Rubra Pilaris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 terminated. 3 Phase 2, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 42Not yet recruiting 1, Terminated 1
Phase 11Completed 1

Follow Pityriasis Rubra Pilaris: new trials by email Literature Review of Pityriasis Rubra Pilaris trials Research Report on Pityriasis Rubra Pilaris

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris (PRP)
Bimekizumab - Pityriasis Rubra Pilaris
Phase 4Not yet recruitingMayo Clinic122026-10-012026-09-08
Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris
Deucravacitinib - Pityriasis Rubra Pilaris
Phase 2CompletedMayo Clinic72024-07-292026-08-26
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
guselkumab - Pityriasis Rubra Pilaris
Phase 2CompletedOregon Health and Science University152019-10-032024-05-24
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
Ixekizumab - Pityriasis Rubra Pilaris
Phase 2CompletedOregon Health and Science University122018-05-232020-07-01
Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris
Cosentyx - PITYRIASIS RUBRA PILARIS
Phase 1CompletedMayo Clinic122018-04-012022-02-24
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Alefacept - Pityriasis Rubra Pilaris
Phase 4TerminatedJoshua Zeichner12008-12-012018-05-11

Narrower conditions

Skin Diseases (1)

Broader conditions

Pityriasis (6)  ·  Skin Diseases, Papulosquamous (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Skin Diseases (5)

Interventions

Alefacept (1)  ·  bimekizumab (1)  ·  deucravacitinib (1)  ·  guselkumab (1)  ·  ixekizumab (1)  ·  secukinumab (1)

Sponsors

Mayo Clinic (3)  ·  Oregon Health and Science University (2)  ·  Joshua Zeichner (1)

Countries

United States (6)

Top investigators

Teri Greiling, MD, PhD (2)  ·  Aaron Mangold, MD (1)  ·  Jason C Sluzevich (1)  ·  Jason C. Sluzevich, MD (1)  ·  Joshua Zeichner, MD (1)

Results publications

PMID 32293641, PMID 35701384, PMID 38598229